Home / Biotechnology / Western Bl

Western Blotting Market By Product Type (Consumables, Instruments, Imagers), By Application (Biomedical And Biochemical Research, Disease Diagnostics, Agri-Biotech), By Usage Area (Research And Academia, Pharmaceuticals And Biotech, Disease Diagnosis) - Growth, Future Prospects, And Competitive Analysis, 2017 -2025

Western blotting, or protein immunoblot, is the technique used for detection and quantification of specific proteins in a sample. This technique forms a major contributor in molecular diagnostics market. Growing prevalence of HIV worldwide, increasing range of applications of western blotting and extensive R&D initiatives being undertaken in this space by biotechnology and pharmaceutical companies are the major drivers of the global western blotting market. Oh the other hand, threat from alternative detection techniques and high price of blotting apparatus and devices may hold back the growth of this market. Some of the major trends observed in the global western blotting market are high investment in research and development, increasing adoption of automation, and introduction of novel imaging software in efficient blotting and detection among others.

The purpose of this research study titled ‘Western Blotting Market - Growth, Future Prospects, and Competitive Analysis, 2017 – 2025’ is to provide investors, developers, company executives and industry participants with in-depth analysis to allow them to take strategic initiatives and decisions related to the prospects in the global western blotting market. This report presents and analyzes the major trends prevalent in the global western blotting market and the market size and forecast.

This report categorizes the global western blotting market in terms of product type, application, usage areas and geographical distribution. Based on product type, the global western blotting market is categorized into consumables (reagents and kits), instruments (gel electrophoresis instruments, blotting systems: wet blotting instruments and semi-dry blotting instruments; and imagers: chemiluminescent imagers, fluorescent imagers and others). Biomedical and biochemical research, disease diagnostics, agri-biotech and others are the chief application areas considered for the purpose of this study. On the basis of usage areas, the global western blotting market is categorized into research and academia, pharmaceuticals and biotech, disease diagnosis, and others. Market size and forecast for each mentioned segment for the period 2015-2025 is presented in the report along with respective CAGRs for the forecast duration 2017-2025.

Geographically, the global western blotting market is best understood by segmenting the market into five major regions and chief region level markets as follows:

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • GCC
    • Rest of Middle East and Africa

The market size and forecast of each considered geographical market is presented for the period 2015-2025 along with CAGRs for the forecast period 2017-2025 in this study and are further cross-sectional presented in terms of product type, applications, usage areas and constituent region/country level markets.

This report also includes qualitative assessment factors such as market dynamics (drivers, restraints and opportunities) to have a good understanding of the current and anticipated trends in the global western blotting market. Competition assessment tools such as, major agreements, partnerships and collaborations, market attractiveness assessment and competitive landscape analysis by key players are also demonstrated in the study. Furthermore, this report concludes with profiling of key market players currently enjoying prominent position in the western blotting market. The key players profiled in this report are Advansta, Inc., Bio-Rad Laboratories, Inc., Bio-Techne Corporation, Cell Signaling Technology, F. Hoffmann-La Roche Ltd., GE Healthcare, LI-COR Biosciences, Merck KGaA, PerkinElmer, Inc., Sigma-Aldrich Co., Thermo Fisher Scientific, Inc. and Trinity Biotech plc.

Based on the usage areas, the global western blotting market is segmented as follows:

  • Research and Academia
  • Pharmaceuticals and Biotech
  • Disease Diagnosis
  • Others

Western Blotting Market

Research and academia segment accounted for the largest share in the global western blotting market. Significant influx of institutional and government funds in research with a focus on introduction of breakthrough technologies and exploratory tools in the field of proteomics and personalized medicine is majorly attributed to the dominance of this segment. Additionally, intention of embarking a footprint in the market through novel drug discovery and diagnostic tools makes pharmaceuticals and biotech a competitive segment. On the other hand, it is expected that disease diagnosis will be the fastest progressing segment during the forecast period. Rapidly growing incidence of infections such as Lyme disease, HIV/AIDS, HBV etc. corresponding to the intent of containing the perpetually growing socioeconomic burden of such diseases drive the growth of this segment.

Geographically, the global western blotting market is cumulative to North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Western Blotting Market

At present, North America and Western Europe account for the largest revenue share in the global western blotting market. Domicile of a large number of market incumbents and research institutes in the regions, evolved research infrastructure and high awareness majorly contribute to the dominance of North America and Europe. On the other hand, alarming growth in incidence of target diseases, particularly Hepatitis and HIV/AIDS and growing trend of outsourcing of research and development contracts in countries such as India, Malaysia and others, drive the Asia Pacific market, thus making it the fastest progressing regional market. the global western blotting market is highly competitive in nature and is characterized by growing penetration activities of large market players in emerging economies, increasing strategic collaborations and M&A activities.

The detailed regional classification of the global western blotting market is as follows:

  • North America (U.S. & Canada)
  • Europe (Germany, U.K., and Rest of Europe)
  • Asia Pacific (China, Japan and Rest of Asia Pacific)
  • Latin America (Brazil, Mexico, and Rest of Latin America)
  • Middle East and Africa (GCC and Rest of Middle East and Africa)
Choose License Type
Published Date:  Aug 2017
Category:  Biotechnology
Report ID:   58630
Report Format:   PDF
Pages:   120
Rating:    4.2 (40)
Connect With Us
24/7 Research Support